Als Therapy Development Foundation Inc
Als Therapy Development Foundation Inc's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $414,933 for Fernando Vieira, Ceo And Cso (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $425,851. It is higher than the D + F figure for 31 of 44 peer organizations selected under the disclosed tier Same NTEE major group (H), nationwide + size band 0.77–1.3× revenue (approximately 70%; median $308,873). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Als Therapy Development Foundation Inc, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.77–1.3× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Friedreich's Ataxia Research Alliance | VA | $13,135,426 | $183,312 |
| Research To Prevent Blindness | NY | $13,097,577 | $107,268 |
| Cvpath Institute Inc | MD | $13,092,271 | $647,734 |
| Lungevity Foundation Inc | IL | $13,750,114 | $303,626 |
| Health Effects Institute | MA | $12,968,951 | $291,407 |
| New Jersey Health Foundation Inc | NJ | $13,963,524 | $605,635 |
| Rheumatology Research Foundation | GA | $13,965,881 | $51,892 |
| South Shore Health Express Inc | MA | $13,990,021 | $188,130 |
View the organization record and available filings on ProPublica